- Poland
- /
- Healthtech
- /
- WSE:SNT
Is Now The Time To Put Synektik Spólka Akcyjna (WSE:SNT) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Unfortunately, these high risk investments often have little probability of ever paying off, and many investors pay a price to learn their lesson. While a well funded company may sustain losses for years, it will need to generate a profit eventually, or else investors will move on and the company will wither away.
Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Synektik Spólka Akcyjna (WSE:SNT). While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing.
Check out our latest analysis for Synektik Spólka Akcyjna
Synektik Spólka Akcyjna's Improving Profits
Strong earnings per share (EPS) results are an indicator of a company achieving solid profits, which investors look upon favourably and so the share price tends to reflect great EPS performance. So for many budding investors, improving EPS is considered a good sign. It's an outstanding feat for Synektik Spólka Akcyjna to have grown EPS from zł0.77 to zł3.24 in just one year. When you see earnings grow that quickly, it often means good things ahead for the company. But the key is discerning whether something profound has changed, or if this is a just a one-off boost.
Top-line growth is a great indicator that growth is sustainable, and combined with a high earnings before interest and taxation (EBIT) margin, it's a great way for a company to maintain a competitive advantage in the market. The good news is that Synektik Spólka Akcyjna is growing revenues, and EBIT margins improved by 5.8 percentage points to 12%, over the last year. That's great to see, on both counts.
The chart below shows how the company's bottom and top lines have progressed over time. Click on the chart to see the exact numbers.
Since Synektik Spólka Akcyjna is no giant, with a market capitalisation of zł548m, you should definitely check its cash and debt before getting too excited about its prospects.
Are Synektik Spólka Akcyjna Insiders Aligned With All Shareholders?
It should give investors a sense of security owning shares in a company if insiders also own shares, creating a close alignment their interests. Shareholders will be pleased by the fact that insiders own Synektik Spólka Akcyjna shares worth a considerable sum. Indeed, they hold zł150m worth of its stock. That's a lot of money, and no small incentive to work hard. Those holdings account for over 27% of the company; visible skin in the game.
Is Synektik Spólka Akcyjna Worth Keeping An Eye On?
Synektik Spólka Akcyjna's earnings per share growth have been climbing higher at an appreciable rate. That EPS growth certainly is attention grabbing, and the large insider ownership only serves to further stoke our interest. At times fast EPS growth is a sign the business has reached an inflection point, so there's a potential opportunity to be had here. Based on the sum of its parts, we definitely think its worth watching Synektik Spólka Akcyjna very closely. Before you take the next step you should know about the 2 warning signs for Synektik Spólka Akcyjna (1 can't be ignored!) that we have uncovered.
Although Synektik Spólka Akcyjna certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see insider buying, then this free list of growing companies that insiders are buying, could be exactly what you're looking for.
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WSE:SNT
Synektik Spólka Akcyjna
Provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland.
Outstanding track record with flawless balance sheet.